This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2002 Sep-Oct;15(5):315-28.

doi: 10.1046/j.1525-139x.2002.00077_1.x.

How should hyperphosphatemia be managed in dialysis patients?

Geoffrey Block¹, Jaime Uribarri, Joseph A Coladonato, Stanley L S Fan, John Cunningham, Charles R Nolan, Wajeh Y Qunibi, Jill S Lindberg

Affiliations

PMID: 12358631
DOI: 10.1046/j.1525-139x.2002.00077_1.x

Review

How should hyperphosphatemia be managed in dialysis patients?

Geoffrey Block et al. Semin Dial. 2002 Sep-Oct.

. 2002 Sep-Oct;15(5):315-28.

doi: 10.1046/j.1525-139x.2002.00077_1.x.

Authors

Geoffrey Block¹, Jaime Uribarri, Joseph A Coladonato, Stanley L S Fan, John Cunningham, Charles R Nolan, Wajeh Y Qunibi, Jill S Lindberg

Affiliation

¹ Denver Nephrology, Denver, Colorado. gblock@denverneph.net

PMID: 12358631
DOI: 10.1046/j.1525-139x.2002.00077_1.x

No abstract available

PubMed Disclaimer

Similar articles

Management of hyperphosphataemia in chronic renal disease: lessons from the past and future directions.
Amato M, Aterini S. Amato M, et al. Nephrol Dial Transplant. 2003 Apr;18(4):848; author reply 848-9. doi: 10.1093/ndt/gfg014. Nephrol Dial Transplant. 2003. PMID: 12637666 No abstract available.
Hyperphosphataemia and treatment with sevelamer in haemodialysis patients.
Cizman B. Cizman B. Nephrol Dial Transplant. 2003 Jul;18 Suppl 5:v47-9. doi: 10.1093/ndt/gfg1046. Nephrol Dial Transplant. 2003. PMID: 12817070 Review.
Understanding and managing hyperphosphatemia in patients with chronic renal disease.
Malluche HH, Monier-Faugere MC. Malluche HH, et al. Clin Nephrol. 1999 Nov;52(5):267-77. Clin Nephrol. 1999. PMID: 10584989 Review.
New developments in the management of hyperphosphatemia in chronic kidney disease.
McIntyre CW. McIntyre CW. Semin Dial. 2007 Jul-Aug;20(4):337-41. doi: 10.1111/j.1525-139X.2007.00306.x. Semin Dial. 2007. PMID: 17635825 Review.
Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis: results of the CARE study.
Qunibi WY, Nolan CR. Qunibi WY, et al. Kidney Int Suppl. 2004 Sep;(90):S33-8. doi: 10.1111/j.1523-1755.2004.09006.x. Kidney Int Suppl. 2004. PMID: 15296505 Review.

See all similar articles

Cited by

Recent publications by ochsner authors.
[No authors listed] [No authors listed] Ochsner J. 2003 Spring;5(2):57-62. Ochsner J. 2003. PMID: 21765756 Free PMC article. No abstract available.
Do oral aluminium phosphate binders cause accumulation of aluminium to toxic levels?
Pepper R, Campbell N, Yaqoob MM, Roberts NB, Fan SL. Pepper R, et al. BMC Nephrol. 2011 Oct 12;12:55. doi: 10.1186/1471-2369-12-55. BMC Nephrol. 2011. PMID: 21992770 Free PMC article. Clinical Trial.
Efficacy and safety of lanthanum carbonate on chronic kidney disease-mineral and bone disorder in dialysis patients: a systematic review.
Zhang C, Wen J, Li Z, Fan J. Zhang C, et al. BMC Nephrol. 2013 Oct 17;14:226. doi: 10.1186/1471-2369-14-226. BMC Nephrol. 2013. PMID: 24134531 Free PMC article.
Management of hyperphosphataemia in dialysis patients: role of phosphate binders in the elderly.
Lorenzo Sellares V, Torres Ramírez A. Lorenzo Sellares V, et al. Drugs Aging. 2004;21(3):153-65. doi: 10.2165/00002512-200421030-00002. Drugs Aging. 2004. PMID: 14979734 Review.
Recent publications by ochsner authors.
[No authors listed] [No authors listed] Ochsner J. 2003 Winter;5(1):55-7. Ochsner J. 2003. PMID: 21765755 Free PMC article. No abstract available.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information